Sign in

CIK 0000876343

  • Non-accelerated filer
  • Smaller reporting company

Lineage Cell Therapeutics, Inc.

Sign in to watch
Ticker
LCTX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
943127919
Phone
+1 510-521-3390
Business address
2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
Former names
BIOTIME INC
  1. 5 Insider Annual Insider Trading Report
  2. 4 Open-market sale Previous 10% Owner sold 2,383,090 shares at $2.16 ($5,137,942)
  3. 4 Shares withheld for taxes President and CEO gave up 5,343 shares (to pay taxes)
  4. 4 Shares withheld for taxes President and CEO gave up 5,343 shares (to pay taxes)
  5. 4 Shares withheld for taxes President and CEO gave up 21,371 shares (to pay taxes)
  6. 4 Open-market sale 10% owner sold 4,000,000 shares at $1.66 ($6,640,000)
  7. 4 Open-market buy Director bought 24,553 shares at an average $0.98 ($24,045)
  8. 4 Open-market buy General Counsel/Secretary bought 5,000 shares at $1.02 ($5,100)
  9. 4 Open-market buy CFO & SVP, Finance bought 5,000 shares at $1.01 ($5,050)
  10. 4 Open-market buy President and CEO bought 10,000 shares at $1.01 ($10,100)
  11. 4 Open-market sale 10% owner sold 2,250,000 shares at $2.00 ($4,500,000)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 8 of 36 · 720 filings